Intrathymic injection of the Abelson murine leukemia virus (A-MuLV
INTRODUCTION
The ability of the v-abl oncogene of the Abelson murine leukemia virus (A-MuLV) to immortalize immature lymphoid cells from bone marrow and fetal liver has been useful for identifying and characterizing immature stages of B-cell development (Rosenberg and Witte, 1988; Alt et al., 1984) . Depending on the extent of Igh rearrangement, most transformed cell lines derived from A-MuLV infected bone marrow or fetal liver can be divided into one of three categories. Cell lines in the most common category represent transformed pre-B cells that exhibit complete variable region formation on at least one allele.
However, because of the imprecision of VHDJH recombination, these transformants may or may not express cytoplasmic mu chains (Cg) (Alt et al., 1984) . Even if a functional Igh variable region is formed and Ct is expressed, these pre-B cell transformants are usually arrested at this stage of B-cell differentiation by v-abl suppression of RAG gene expression and/or inhibition of NF-KB/rel-mediated intron enhancer activity Klug et al., 1994) .
A second marrow-derived A-MuLV-transformed cell type is arrested at the DJ H stage of maturation. These cells fail to rearrange V H to DJ H and are referred to as DJ-fixed (DJ-f) (Ramakrishnan and Rosenberg, 1988; Wang and Rosenberg, 1993) . A-MuLV transformed cell lines derived from fetal liver also have rearranged only DJ H segments, but unlike the DJ-f population obtained from marrow, are not blocked at this stage of development and continue assembling Igh genes so that _<10% of the cells express Cg. This third type of A-MuLV transformant is referred to as DJ-rearranging (DJ-r) (Ramakrishnan and Rosenberg, 1988) .
Thymic lymphocytes can also be transformed by A-MuLV (Clark et al., 1993; Cook, 1982; Cook, 1985; Cook and Balaton, 1987; Holland et al., 1991; Kimoto et al., 1989; Risser et al., 1985; Scott et al., 1986; D'Andrea et al., 1987) , and these can be divided into three categories based on their level of Thy-1 expression (Clark et al., 1993; Cook, 1982; Cook, 1985; Cook and Balaton, 1987; Scott et al., 1986) . Transformed thymocytes that express high levels of Thy-1 (Thy-1hi) are also B220-and have rearranged their TCR/ and 3 genes. These represent early-to-intermediate stages of ?/6 or t/ T-cell development (Clark et al., 1993; Cook, 1982; Cook, 1985; Cook and Balaton, 1987; Holland et al., 1991; Risser et al., 1985; Scott et al., 1986) . Other A-MuLV transformed thymic lymphocytes do not express Thy-1 (Cook, 1982; Cook, 1985; Cook and Balaton, 1987; Kimoto et al., 1989; Risser et al., 1985; Scott et al., 1986; D'Andrea et al., 1987) , and when examined, express B220 (Kimoto et al., 1989; Risser et al., 1985; Scott et al., 1986) . These have extensively rearranged Igh genes and often have rearranged Ig and TCR7 genes, but maintain unrearranged TCRI3 genes (Cook and Balaton, 1987; Kimoto et al., 1989; Scott et al., 1986; D'Andrea et al., 1987) . Therefore, this A-MuLV-transformed thymocyte population consists of pre-B cells, similar to the common marrow-derived A-MuLV transformant. Thus, rare B-progenitor cells that can be transformed by A-MuLV appear to exist in the thymi of adult mice. The origin of these cells and their relationship to marrow-derived B-progenitor cells are not understood at this time.
Also of interest are the relatively rare A-MuLVinduced thymoma-derived cell lines reported to express low levels of Thy-1 (Thy-ll) (Cook, 1982; Cook, 1985; Cook and Balaton, 1987; Holland et al., 1991) because in murine hematolymphoid populations, Thy-11 often characterizes progenitor and stem cells (Kondo et al., 1997; Lian et al., 1997; McKenna and Morrissey 1998; Morrison and Weissman 1994; Miiller-Sieburg et al., 1986; Soloffet al. 1997 ). In addition, Thy-11 is also found expressed on early thymic progenitors (Antica et al. 1994; Carlyle et al. 1997; Hattori et al? 1994; Kawamoto et al. 1999; Wu et al. 1991) . Unlike the other categories of A-MuLV-transformed thymoma cells that clearly represent distinct stages of T or B-cell development, the few A-MuLV-transformed Thy-11 cell lines that have been examined express an ambiguous phenotype that cannot unequivocally be assigned to a particular stage of T or B lymphocyte development (Cook, 1985; Cook and Balaton, 1987; Risser et al., 1985; D'Andrea et al., 1987; Holland et al., 1991) . These thymoma cells may be analogous to cases of acute human leukemia in which malignant lymphoblasts with an ambiguous phenotype are thought to arise from the transformation of a transitory lymphoid progenitor poised at the juncture of commitment to either the T or B-lymphoid lineage (Paietta, 1992; Greaves, 1986) . Since progenitor populations capable of giving rise to both T and B-cells can be found in the thymi of adult and fetal mice (Akashi et al. 1998; Hattori et al. 1994; Matsuzaki et al., 1993; Peault et al. 1994; Wu et al., 1991) FIGURE Coexpression of B220 and Thy-11 cells on immature lymphocytes in primary thymomas induced by A-MuLV. Three representative thymomas in which 35%, 67% and 80% of the cells were B220 were analyzed for coexpression of B220 and Thy-1 by two color flow cytometry as described in the Materials and Methods. The data show that the B220 cells expressed low levels of Thy-1, and that B220-cells were Thy-1hi. This is representative of 22 thymic tumors analyzed. B220 cells were also sorted to >95% purity over the anti-B220 magnetic column then stained with (solid histograms) FITC-R6-60.2 (anti-IgM), FITC-S7 (anti-CD43), PE-53-7.3 (anti-CD5), PE-RM2-5 (anti-CD2), or PE-M1/69 (anti-HSA) (data not shown) and analyzed by flow cytofluorometry. Isotype-matched irrelevant antibodies were used to establish background fluorescence (open histograms). These data are representative of nine Thy-11 B220 tumor populations that were examined. Staining profiles for normal thymus and electronically gated apleen and bone marrow B220 cells are included for control.
While comparing thymomas induced by intrathymic injection of different retroviruses, we noticed that distinct Thy-ll and Thy-lhi populations often co-existed in the same primary tumor that was induced with either the v-abl or BCR-ABL oncogenes.
In contrast, we only observed Thy-lhi cells in tumors induced with the Moloney murine leukemia virus (Clark et al., 1993) . The Thy-11 tumor cells could represent the in vivo counterpart of the rare Thy-11 A-MuLV transformed thymoma derived cell lines that are of an undetermined stage of lymphocyte development (Cook, 1985; Cook and Balaton, 1987; Holland et al., 1991) . Since the Thy-1 l category of A-MuLV transformed thymomas may be relevant to early lymphocyte development (Clark et al., 1993; Cook, 1985; Cook and Balaton, 1987; Holland et al., 1991) (Clark et al., 1993) . Further examination revealed that B220 + cells also were present at approximately the same frequency as the Thy-1 l cells (Clark et al., 1993) . Therefore, we used two-color flow cytometry to determine whether cells in A-MuLV-induced thymomas coexpress . This analysis revealed the presence of two major thymoma subpopulations that could be distinguished by their phenotype. One subpopulation expressed high levels of Thy-1 and was B220-. The second subpopulation was B220 + and expressed Thy-1 at about a 10-fold lower peak fluorescence than the Thy-lhi population (Fig. 1) Because it was difficult to obtain high resolution on DNA blots of the sorted subpopulations, we used the PCR strategy illustrated in Fig. 2 to quantitate the relative proviral content in order to evaluate the contribution of A-MuLV infected cells to each sorted tumor subpopulation. Bands from the PCR reactions were quantitated by Phosphorimager and the relative proviral content of each subpopulation was calculated as the intensity of the 491 bp proviral gag-abl band normalized to the intensity of the 737 bp actin band. These values were checked against the proviral contents of standards prepared by serially diluting DNA from a v-abl transformed pre-B cell line with DNA from normal liver (Fig. 2 , lanes 1-5). In the sorted B220 + (Fig. 3 , lanes 9-14) and B220-(data not shown) tumor subpopulations, the mean relative proviral content was 0.7 (range 0.5-1.0), which was somewhat higher than the 0.5 mean relative proviral content of four clonal v-abl transformed bone marrow cell lines (Fig. 3 , lanes 5-8, range 0.4-0.5). Nevertheless, this confirmed that both B220 + and B220-thymoma subpopulations were infected with A-MuLV. In contrast to the Thy-ll B220 + thymoma subpopulation, Thy-1 hi B220-tumor cells (Fig. 4A and 4B , lanes 2, 4, 6, and 9) and normal thymus (lane 14)
showed extensive rearrangement of both TCR' and TCR[3 genes by DNA blot analysis. TCR' rearrangement was evident by 33-68% loss of germline bands (Fig 4D, lanes 2, 4, 6 , and 9) and by the appearance of rearranged bands (Fig 4A, lanes 2, 4, 6 , and 9). TCR rearrangement was also apparent by the 54-59% loss of the CI31 germline band (Fig. 4B and 4D , lanes 2, 4, 6, and 9). Since the TCR3 probe detects the 3' untranslated region of C31 and does not cross-hybridize with C[2, complete loss of the C131 germline sequences without the appearance of rearranged bands in these oligoclonal populations is likely due to rearrangement involving C12 (Clark et al., 1993 In bone marrow a Thy-11 B220 + B-lymphoid progenitor population is highly enriched for A-MuLV transformation targets (Tidmarsh et al., 1989) (Clark et al., 1993; Cook, 1982; Cook, 1985; Cook and Balaton, 1987; Holland et al., 1991; (Hardy et al., 1989; Hardy, et al., 1991; Li et al., 1996; Nutt et al., 1997; Rolnick et al., 1996; Sen et al., 1990; Winkler et al., 1995; Yagita et al., 1989) and similar to the phenotype of A-MuLV transformed bone marrow pre-B cells (Rosenberg and Kincade, 1994) . However, the fact that a significant proportion of these cells had not rearranged Igh genes is inconsistent with the observation that they express HSA which first appears on B lymphocyte progenitors in the process of rearranging the D to JH region (Allman et al., 1999; Nutt et al., 1997) . (Duplay et al., 1989; Scollay and Shortman, 1985) . As the cells mature, expression of CD2 and CD5 increase (Duplay et al., 1989; Sen et al., 1989) while HSA levels decrease (Scollay and Shortman, 1985; Crispe and Bevan, 1987 (Heuze et al., 1992) , v-myc (Brightman et al., 1988) and RadLV (Ho and O'Neill, 1993) have been reported. In addition, autoimmune-prone strains of mice often carry B220 / T-lymphocytes (Matsuzaki et al., 1992; Landolfi et al., 1993; Giese et al., 1994) which develop from thymic B220 / progenitor cells (Budd et al., 1985; Asensi et al., 1990) . However, while these cells are usually found in autoimmune-prone mice and express CD5, the Thy-1 l B220 + thymoma subpopulation was uniformly CD5-. The B220 antigen was also reported to be expressed on a minor subpopulation of immature CD4-8-double negative (DN) thymocytes from normal mice as well as on DN thymocytes undergoing apoptosis (Mixter et al., 1999 (Cook, 1982; Cook, 1985; Cook and Balaton, 1987; Holland et al., 1991; Kimoto et al., 1989; Risser et al., 1985; Scott et al., 1986 ). (Clark et al., 1993; Cook, 1982; Cook, 1985; Cook and Balaton, 1987; Holland et al., 1991; Kimoto et al., 1989; Risser et al., 1985; Scott et al., 1986) . Nevertheless, the Thy-l B220 + progenitor-like cells in the primary thymomas do share similarities with some other transformed lymphoid populations. For instance, these progenitor-like lymphocytes closely resemble thymomas that arise in bcl-2/myc transgenic mice (Strasser et al., 1990) (Allman et al., 1999) , it is possible that these progenitor-like thymoma cells may already be committed to either the T or B lymphoid lineage. Experiments are underway to attempt to resolve this issue.
Thymic targets for A-MuLV transformation
The progenitor-like thymoma population expressed a Thy-11 B220 / phenotype that is similar to bone marrow derived B-lymphoid progenitors that are enriched for A-MuLV transformation targets (Tidmarsh et al., 1989) . This similarity raised the possibility that a B-cell progenitor in the adult thymus is a target for transformation by v-abl. However In summary, these observations suggest that a subset of the Thy-11 B220 / thymoma population represents an undifferentiated lymphoid progenitor that cannot be unequivocally assigned to either the T or B-lymphoid lineage. It will be of interest to identify the normal thymocyte target that gives rise to this transformed progenitor population and to assess its capacity for differentiation.
MATERIALS AND METHODS

Retrovirus
A-MuLV (1-2 x 105 focus forming units per ml) was collected from clonal NIH 3T3 fibroblast cells infected with a helper-free A-MuLV and superinfected with Moloney murine leukemia virus (Mo-MuLV). To make a concentrated preparation of A-MuLV, viral supernatant was centrifuged over a 20% sucrose cushion, and the virion pellet was gently resuspended in 0.01 volumes of media (Wang et al., 1991 For phenotypic and genotypic analyses of B220 + cells in tumor populations that also contained B220-cells, B220 + cells were separated over a magnetic column as described by others (Miltenyi et al., 1990) . Basically, cells were incubated with RA3-6B2-coupled superparamagnetic microbeads (anti-B220; Miltenyi Biotec Inc., Sunnyvale, CA) at 10 gl anti-B220 beads per 10 7 thymoma cells, or at 10 gl per 108 normal thymocytes. After 10 min., biotinylated RA3-6B2 (Pharmingen, San Diego, CA) (2.5 gg/ml) was added and the cells were incubated for an additional 20 minutes at 4C. This permitted indirect immunofluorescent detection of B220 expression of column sorted populations. Cells were washed in cold staining buffer and passed over a magnetized A2 separation column according to the manufacturer's protocol (Miltenyi Biotec Inc.) . Cells that flowed through were collected as the B220-fraction. To collect the B220 + fraction, the column was removed from the magnetic field and the adherent cells were washed from the column with cold staining buffer. The efficiency of separation was assessed by flow cytometry after staining with avidin conjugated fluorescein-isothiocyanate (FITC) (Becton-Dickinson, Mountain View, CA). From thymomas with mixed populations of B220-and B220 + cells, this protocol routinely gave >95% B220 + cells from the column and <5% in the flow-through fraction. From normal thymi where B220 + cells represented <0.3% of the population, B220 + cells were enriched 100-fold over the column and further purified to homogeneity by FACS.
Immunofluorescent cell staining and flow cytometry Immunofluorescent cell staining was performed as described before (Clark et al., 1993) , except that cells were preincubated with FcBlock (Pharmingen) in order to prevent potential Fc receptor binding of monoclonal antibodies. Strategies for simultaneous analysis of multiple surface antigens were essentially as described by Hardy et al. (Hardy et al., 1991) . After cells were flow sorted, an aliquot was reanalyzed by flow cytometry in order to confirm the sorting efficiency. PCR analysis was performed on sorted populations that were 95-98% pure.
Cell cycle analysis
Simultaneous staining of cell surface antigens and nuclear DNA was done exactly as described previously (Schmid et al., 1991 (Clark et al., 1993) . The genomic 4.7 kb c-myc fragment from pmyc-26 contains c-myc exons 1, 2 and 3 and was kindly provided by Dr. Richard Schwartz (Michigan State University).
PCR quantitation of relative proviral content
In order to measure relative v-abl provirus content in different tumor populations, a 491 bp gag-abl fragment was amplified by PCR using primers specific for retroviral gag (5' TCC ACT ACC TCG CAG GCA TTC 3') and abl (5' CCT CCA CCC AAC TTG TGC TTC 3') sequences. Amplification of a 737 bp region of the ot-actin gene (Hardy et al., 1991) The parameters for PCR amplification of Ig genes were identical to those described above, except that 0.1 mg of EcoRI-digested genomic DNA was used as template, the reaction buffer contained 2.0 mM MgC12, and 23 cycles of amplification were performed. Unrearranged IgH and IgL products and the actin fragment amplified from liver DNA were used as probes. The Ig amplification signal from each tumor sample was normalized to the actin signal amplified in the same tube, and this value was compared to a similarly normalized unrearranged Ig amplified signal from liver in order to quantitate the loss of Ig germline structure. Each sample was amplified and analyzed 3-6 times.
